Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

A treatment room view

February 24, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, Roche, avastin, hinsely

A little more than a year ago, Lisa Hinsley’s prospects were not good. The mother of three had been diagnosed …
Feature

New VP of Operations for Exco InTouch

February 24, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exco InTouch, burke

Healthcare data services firm Exco InTouch has appointed Laurence Burke as its vice president of Operations. Burke takes over 20 …
Appointment

‘Compassionate’ use of hep C combo

February 24, 2014 Research and Development, Sales and Marketing CHMP, EMA, Gilead, hep C, ledipasvir, sovaldi

A key adviser to the European regulator has said that Gilead Sciences’ fixed-dose combination of Sovaldi and ledipasvir can be …
News

Lilly drug improves lung cancer survival

February 21, 2014 Research and Development, Sales and Marketing NSCLC, lilly, necitumumab, ramucirumab

News

New head of Biosimilars for Merck KGaA

February 21, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biosimilars, simon sturge

Simon Sturge is joining Merck KGaA from Boehringer Ingelheim in order to head its Biosimilars unit. In his new role …
Appointment

Pharma sponsored ‘weekend family gathering’

February 21, 2014 Medical Communications, Sales and Marketing ABPI, Facebook, PMCPA

News

GSK/Theravance lung drug bags CHMP approval

February 21, 2014 Sales and Marketing CHMP, COPD, GSK, Theravance, anoro

The CHMP has given its backing to GlaxoSmithKline and partner Theravance’s new chronic obstructive pulmonary disease medicine Anoro. The treatment …
News

Avillion appoints pharma veteran as chief executive

February 21, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allison Jeynes-Ellis, Avillion

Drug development firm Avillion has appointed Dr Allison Jeynes-Ellis to be its chief executive. By stepping into the role Jeynes-Ellis …
Appointment

Skin cancer pill shows ‘significant’ response

February 20, 2014 Research and Development, Sales and Marketing LDE225, Novartis, bolt, skin cancer, smo

Novartis is celebrating after its investigational pill targeting the most common form of skin cancer met its primary endpoint in …
News

Police raid Novartis Tokyo office

February 20, 2014 Medical Communications, Sales and Marketing Diovan, Japan, Novartis, tokyo

Authorities in Japan have raided the premises of Novartis’ Tokyo operation as part of an ongoing investigation into the promotion …
News

Apple files healthcare tech headphones

February 20, 2014 Medical Communications, Sales and Marketing Apple, Samsung, iwatch, technology, wearable

A recently-published Apple patent has shed light on a new health-monitoring device that will be built into a pair of …
News

RSA appoints director of Information

February 20, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Claes Zackrisson, rsa

Life sciences executive search and interim management firm RSA has appointed Claes Zackrisson as its first director of information. Zackrisson …
Appointment

Servier signs leukaemia deal

February 19, 2014 Research and Development, Sales and Marketing Servier, UCART19, car, cellectis, leaukaemia

French firms Servier and small biopharma cancer specialist Cellectis have signed a deal to develop and commercialise one drug targeting …
News

Boehringer in hot water over Pradaxa risks

February 19, 2014 Sales and Marketing Boehringer, Pradaxa, Xarelto, dabigatran, lawsuit

Boehringer Ingelheim attempted to delay and revise the publication of important drug information surrounding its new anticoagulant Pradaxa. This is …
News

Vimizin shown green light

February 19, 2014 Research and Development, Sales and Marketing BioMarin, FDA, congenital enzyme disorder, vimizin

Regulators have shown the green light to BioMarin Pharmaceutical’s Vimizim as a treatment for a rare enzyme deficiency which affects …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026